• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Five Prime Therapeutics Inc. - Articles and news items

Bristol-Myers Squibb to develop Five Prime’s CSF1R antibody programme

Industry news / 15 October 2015 / Victoria White

As well as an upfront payment of $350 million, Five Prime will be eligible to receive up to $1.05 billion in development and regulatory milestone payments…

Bristol Myers Squibb logo

Five Prime Therapeutics and Bristol-Myers Squibb sign collaboration agreement to discover novel immuno-oncology therapies

Industry news / 17 March 2014 / Bristol-Myers Squibb

Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company announced that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies…

Lonza and Biowa sign license agreements with FivePrime Therapeutics

News, Supplier news / 13 June 2012 / Lonza

FivePrime has entered into research & commercial agreements with BioWa & Lonza…